October 13 - 14, 2020 | San Francisco, California
Congratulations to the 2019 winners!
| Early Stage Entrepreneur | Late Stage Leader | Diagnostics and Beyond |
|---|---|---|
 |
 |
 |
The Buzz of BIO contest provides an excellent opportunity for companies looking to make the connections needed to take their product to the next phase. Ten biotechs will be nominated in each of the three categories: Early Stage Entrepreneurs, Late Stage Leaders, and Diagnostics and Beyond. The companies with the most number of votes in each category at the end of the voting period will win a complimentary conference registration and company presentation, along with exposure to thousands of industry elites and potential investors. Please note that the contest is open to U.S. companies only.
What is the Buzz of BIO?
Buzz of BIO is a contest that recognizes U.S. based companies with groundbreaking, early stage technologies with the potential for improving our lives. Companies can submit in one of three categories (below) for a chance to win a complimentary Company Presentation and Registration at the BIO Investor Forum (a $6,500 value)!
What is a Company Presentation?
Company Presentations are quick, 13-minute pitches for companies who are currently in or working toward clinical testing and regulated review. They help gain exposure for your company to business development executives, investors, research analysts, and more in BIO One-on-One Partnering™. Learn more about Company Presentations.
To qualify for the Early Stage Entrepreneur Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised less than $25 million USD as of July 1, 2019; have been founded after 2016; and have most recently completed either a Seed or Series A financing round. Companies that have previously presented at the BIO Investor Forum are not eligible for the Early Stage Entrepreneur category but are welcome to apply under the Late Stage Leader category (if the company meets the minimum dollar requirements of the Late Stage Leader category).
To qualify for the Late Stage Leader Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised more than $25 million USD as of July 1, 2019 and have enrolled at least one patient in a company-sponsored clinical trial posted at https://clinicaltrials.gov/.
To qualify for the Diagnostics and Beyond category, companies must be primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies.
How Does the Contest Work?
There are two phases to the Buzz of BIO Contest: Nominations and Voting.
- During the Nominations period, we will collect nominations and review them to ensure they qualify for one of the three categories listed above, and that they meet the guidelines outlined in the contest rules here.
- During the Voting period, nominees are encouraged to promote their participation in the contest via social media, email, etc. in order to drive more votes for their company. The companies that receive the most votes in their respective category will earn the title of the "Buzz of BIO!"
Due to the complexities of international laws regarding contests, only U.S. residents who are 21 years of age or older are eligible to enter. View the Buzz of BIO Contest Rules.